$JNCE: Jounce Therapeutics Presents Reverse Translational, Biomarker …

Date: Saturday, November 10th, 2018

Stock(s) mentioned:

Source: Benzinga (https://www.benzinga.com)

Summary: 10, 2018 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical-stage company focused on the discovery and development of novel …

Full article address: https://www.benzinga.com/pressreleases/18/11/g12675655/jounce-therapeutics-presents-reverse-translational-biomarker-and-precl

Related News:

$JNCE: Jounce Therapeutics (JNCE) CEO Rich Murray on Q4 2018 Results …

$JNCE $ETX: Hedge Funds Are Crazy About Jounce Therapeutics, Inc. (JNCE)

$JNCE: Jounce Therapeutics, Inc. (JNCE) CEO Richard Murray on Q3 2018 …

$JNCE: Jounce Therapeutics to Present Two Posters from the JTX-2011 …

$JNCE: Jounce Therapeutics Founder Dr. James P. Allison Jointly Awarded …

$JNCE: Jounce Therapeutics to Present at the 2018 Cantor Global …

$JNCE: Jounce Therapeutics to Present Nonclinical Translational Data at …

$JNCE $SGMO $GILD $PFE: Biotech Fire Sale: 2 Top Stocks to Buy Next Week

Latest News:

$AAPL: Goldman Sachs hints that Apple’s new credit card will be rolled out internationally

$MU: Samsung Sings the Chip-Making Blues

$MKC $CCL $NEOG $KBH $AAPL $GS: Apple, Samsung, McDonald’s, Uber and Careem – 5 Things You Must Know

$AXS $MMC: Insurers Creating a Consumer Ratings Service for Cybersecurity Industry

$AMZN: Don’t Just ‘Buy Now’! When Shopping on Amazon, You Need to Pay Attention

$BA: Outside the Box: Here’s how Boeing should fix its crisis management around the 737 Max

$FB: Facebook removes accounts from Russia, Iran for ‘coordinated inauthentic behavior’

$SPX: The Stock Market Is Just as Confused About a Potential Recession as You Are

$SSNLF $AAPL $MU: Samsung Warns on Q1 Profit As Weak Memory, Smartphone Demand Weighs on Chipmaker

$AAPL: Stocks Edge Higher, Taking Cues From Bond Markets, As US Curve Remains Inverted

$FTSE $GDAXI $FCHI: European stocks set to open higher as US bond yields rise; growth concerns linger